Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-11Clinical Trial Update: Prediction of Hepatitis C Recurrence in Liver Transplant Recipients
A clinical trial evaluating the prediction of hepatitis C recurrence after liver transplantation was terminated.
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction [Phase 1]
Phase 1 pharmacokinetic study of BMS-914143 in participants with normal renal function and mild to end-stage renal dysfunction; the study ha…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection [Phase 2]
A Phase 2a study evaluating the viral kinetics and safety of telaprevir in participants with genotype 2 or 3 hepatitis C infection is comple…
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: Pharmacogenomic Research in Korean Patients With Hepatitis C
Clinical trial update noting the completion of a pharmacogenomic study in Korean patients with chronic hepatitis C.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Feasibility of a Hepatitis C Virus (HCV) Decision-Making Intervention Among HIV-infected Adults [NA]
A completed clinical trial evaluating the feasibility of a Hepatitis C decision-making intervention in HIV-infected adults.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-17Clinical Trial Update: Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV
This pilot trial evaluating gut mucosal B cells in individuals with HIV infection and hepatitis C has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures [Phase 1, Phase 2]
A safety and tolerability study of nitazoxanide in individuals with HIV and hepatitis C who failed prior treatment (Phase 1/2; completed wit…
-
CLINICAL_TRIALS trial_result · 2013-05-06Clinical Trial Update: TMC435-TiDP16-C125 - Study in Healthy Volunteers to Evaluate the Potential of TMC435 to Increase the Sensitivity of the Skin Towards Exposure to Sun Light [Phase 1]
Phase 1 study in healthy volunteers to evaluate whether TMC435 increases sensitivity of the skin to sunlight; the trial is completed.
-
CLINICAL_TRIALS trial_result · 2013-05-06Clinical Trial Update: TMC435-TiDP16-C117: The Effect of TMC435 on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers [Phase 1]
A Phase 1 study examining whether TMC435 affects electrocardiogram results in healthy volunteers to assess cardiac safety.
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Efficacy of Nitazoxanide in the Treatment of Chronic Hepatitis C Virus (HCV) [Phase 2, Phase 3]
This document reports results from Phase 2 and Phase 3 trials of nitazoxanide for chronic hepatitis C. Results were posted in May 2013.
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants [Phase 2]
This open-label Phase 2 study evaluated telaprevir dosed every 12 or 8 hours in combination with one of two pegylated interferons and ribavi…
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: Interferon α 2b Pharmacovigilance Study [Phase 4]
A Phase 4 pharmacovigilance trial evaluating Interferon alfa-2b in chronic hepatitis C patients has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: Improving Hepatitis C Treatment in Injection Drug Users [Phase 4]
This update reports the completion of a Phase 4 trial evaluating strategies to improve Hepatitis C treatment among injection drug users.
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir [Phase 1]
Phase 1 study examining pharmacokinetic interactions between telaprevir and un-boosted atazanavir in adults with chronic hepatitis C and HIV…
-
CLINICAL_TRIALS trial_result · 2013-04-19Clinical Trial Update: VX-950-TiDP24-C219: A Roll Over Trial for Patients in the Control Group of the C216 Study Who Received Telaprevir Placebo [Phase 3]
This is a completed Phase 3 rollover trial (VX-950-TiDP24-C219) for Hepatitis C in which patients in the control group of the C216 study rec…
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing. [Phase 1]
Phase I study evaluating drug-drug interaction between TMC435350 and rifampin after multiple dosing in Hepatitis C patients.
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Polymorphisms of Fibrosis-Relating Genes on Outcome of HCV-Related Chronic Liver Disease [NA]
This clinical trial update reports on polymorphisms of fibrosis-related genes and their association with outcomes in hepatitis C-related chr…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients [Phase 4]
Clinical trial update describing a Phase 4 study evaluating nitazoxanide, interferon alfa, and ribavirin for hepatitis C in patients with ty…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients [Phase 2]
Phase 2 trial evaluating tacrolimus-based immunosuppression with steroids versus a monoclonal anti-IL2R antibody in hepatitis C–positive liv…
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: TMC435-TiDP16-C112 - Interaction Trial With Antidepressants [Phase 1]
Phase 1 interaction trial evaluating telaprevir (TMC435) with antidepressants in hepatitis C patients has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: TMC435-TiDP16-C119 - A Study Comparing 2 New Capsule Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Respective Blood Levels of TMC435 Following Single Dose Administration [Phase 1]
A Phase 1 study comparing two new capsule formulations of TMC435 with an established capsule and assessing blood levels after a single dose …
-
CLINICAL_TRIALS trial_result · 2013-04-08Clinical Trial Update: Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)
Completed post-marketing surveillance study P04584 evaluated treatment with PegIntron Pen and Rebetol in HIV-infected patients with chronic …
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Liver Transplantation [Phase 2]
A Phase 2 clinical trial evaluating pre-transplant treatment to prevent hepatitis C recurrence after liver transplantation has completed, wi…
-
CLINICAL_TRIALS trial_result · 2013-04-01Clinical Trial Update: A Follow-up Study to Assess Resistance to ABT-072 in HCV-infected Subjects Administered ABT-072 in Prior ABT-072 Studies [Phase 2]
A Phase 2 follow-up trial to assess resistance to ABT-072 in subjects with hepatitis C who previously received ABT-072; the study is complet…
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Escitalopram for the Prevention of PEGASYS-associated Depression in Hepatitis C Virus-infected Patients [Phase 3]
Phase 3 trial evaluating whether escitalopram prevents pegylated interferon–associated depression in hepatitis C patients; results have been…